APA (7th ed.) Citation

SK, L., LH, C., GC, C., YH, T., WC, S., YM, C., . . . PC, Y. (2021). Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokers. Frontiers in oncology, 11, 753788. https://doi.org/10.3389/fonc.2021.753788

Chicago Style (17th ed.) Citation

SK, Liang, et al. "Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokers." Frontiers in Oncology 11 (2021): 753788. https://doi.org/10.3389/fonc.2021.753788.

MLA (9th ed.) Citation

SK, Liang, et al. "Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokers." Frontiers in Oncology, vol. 11, 2021, p. 753788, https://doi.org/10.3389/fonc.2021.753788.